Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05348889 |
| Title | First-in-Human (FIH) Trial of 1A46 in Subjects With Advanced CD20 and/or CD19 Positive B-cell Hematologic Malignancies |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Chimagen Biosciences, Ltd |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Yale New Haven Hospital | New Haven | Connecticut | 06510-3220 | United States | Details | |
| Norton Cancer Institute | Louisville | Kentucky | 40202-1840 | United States | Details | |
| UPMC CancerCenter | Pittsburgh | Pennsylvania | 15232-1309 | United States | Details | |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030-4000 | United States | Details | |
| Froedtert & the Medical College of Wisconsin Froedtert Hospital | Milwaukee | Wisconsin | 53226-3522 | United States | Details |